CORE Diagnostics: Destination for all High-end Diagnostic Testing
Co-Founder & MD
Specializing in Cardiology, Oncology, Reproductive and Endocrinology tests (CORE), the company provides a range of esoteric tests in the fields
CORE caters services within the shortest turnaround time in the industry by heavily leveraging cmmunication technology and digital imaging
The Serendipitous Journey
Brought up in a family of physicians and healthcare executives, improving the quality and delivery of healthcare in India was always in the consciousness of Zoya Brar (Co-Founder & MD). She stumbled upon the idea behind CORE during a dinner conversation and quit her job at Google the very next month. While writing the business plan was easy, understanding the pain points in the system took an arduous six months, since the end customers were unable to articulate it. Fortunately, she ran into one of the Managing Directors at Artiman Ventures with vast Diagnostics & Oncology expertise. With his guidance, CORE closed Rs.27 crore financing round with Artiman. Today, having won prestigious awards and acquired all major hospitals and Oncology
Firmly believing that the diversity of viewpoints and their meaningful integration is a key enabler for innovation, the company actively encourages conflict – even during recruitment process. Beyond the unique hiring and induction approach, CORE ensures a continuous self-directed learning by creating a very flat culture – no hierarchy, full transparency and brutal candor. Reinforcing its commitment to transparency, CORE’s glass-walled office building has no individual offices, but labs, conference rooms, brainstorming areas, training areas, and one large community table at which everyone sits – CEO included.
Apart from conducting regular internal trainings, the company also sends its people for external trainings/conferences/workshops and CMEs from time to time. Going forward, CORE aims to further improve this unprecedentedly transparent work culture and retain INNOVATION as a brand-synonym with CORE. Judging by its aspiration to truly revolutionize Clinical Diagnostics in India, it is safe to say that CORE will be a global benchmark within a five-year period.